Market Data
Pricing
Solutions
Log In
Market Overview
Financials
Asset Management
Parent Companies
Taizhou Huaxin Pharmaceutical Investment Co Ltd
Huaxin Pharmaceutical Hong Kong Co Ltd
2017-1
Huaxin Pharmaceutical Hong Kong Co Ltd (HAXNP) 2017-1
HYC
FNCL
HAXNP 2017-1 (USD 120m)
Taizhou Huaxin Pharmaceutical Investment Co Ltd
HAT
APAC
Oct 17, 2017
Missing something? Tell us.